Conquering the Final Hurdle of Cell Therapy Commercialization: Sony Senior Manager to Share Exclusiv
Exhibitor: CELL-BIO BIOTECHNOLOGY CO., LTD.
Date: 2025-07-16
Booth No.: L230
TAIPEI, Taiwan – July 16, 2025 – The most significant challenge in bringing a cell therapy product from the lab to the market is scaling up production in compliance with Good Manufacturing Practice (GMP). Ensuring cell sterility, high viability, and purity during the sorting process is the final-mile hurdle that determines a product's success. To address this, Cell Bio Biotechnology will proudly welcome Marc-Aurele Brun, Senior Manager of the Cell Therapy Business at SONY Corp., for a critical presentation at BioAsia 2025 on July 24.
The seminar, titled "Precision Sorting of Specific Cell Subpopulations: Bringing Unprecedented Sterility, Purity, and Automation to Your GMP Process with the Sony CGX10," will directly address the core challenges faced during the clinical and commercial manufacturing stages of cell therapy products.
Global technology leader SONY has leveraged its deep expertise in optics, fluidics, and automation to develop the revolutionary CGX10 Cell Isolation System. Speaker Marc-Aurele Brun will personally detail how the system's innovative, fully closed, sterile microfluidic chip technology fundamentally eliminates the risk of aerosol-induced contamination common in traditional cell sorters, thus guaranteeing the highest level of sterility.
"In the past, high-performance cell sorting and strict GMP compliance often seemed mutually exclusive," remarked the General Manager of Cell Bio Biotechnology. "The arrival of the Sony CGX10 has completely changed the game. It not only delivers exceptional sorting performance and purity but is also purpose-built for GMP processes with its automation and closed-system design. This is precisely the kind of cutting-edge tool Taiwan's cell therapy industry needs to compete on the global stage. We are thrilled to present this landmark solution to the industry's leaders at BioAsia."
This seminar is an unmissable opportunity for all teams involved in the development of cell, gene, and immunotherapies, especially those planning for or already engaged in GMP manufacturing.
Event Details:
-
Seminar: Precision Sorting of Specific Cell Subpopulations: Bringing Unprecedented Sterility, Purity, and Automation to Your GMP Process with the Sony CGX10
-
Speaker: Marc-Aurele Brun, Senior Manager, Cell Therapy Business, SONY Corp.
-
Date & Time: Thursday, July 24, 2025, 3:00 PM - 3:50 PM
-
Location: Room 505C, TaiNEX 1, Taipei
-
Final Call for Registration: Seats for this seminar are nearly full. Scan the QR code on the event flyer or register online immediately to secure your valuable opportunity to engage with an expert from a world-leading corporation. https://forms.gle/Kf4xicA1GZd6Fchk6
About Cell Bio Biotechnology
Cell Bio Biotechnology is a leading supplier in Taiwan's regenerative medicine and cell research sectors, dedicated to introducing the world's most advanced instruments and technologies. We provide comprehensive solutions for clients from basic research to clinical applications. More than just a distributor, we are a trusted partner, empowering our clients to overcome challenges and drive innovation through professional technical support and expert consulting services.
More Exhibitor's Press Release
- Link-Best debuted at BIO Asia Exhibition. Products attracted attention and Ignited Spark. LINK-BEST BIOSCIENCE CO., LTD. / 2025-08-20
- IOT無線連續監測系統 - 廠房、倉儲、實驗室 溫、濕度測繪 XIN TOP CORPORATION / 2025-08-20
- GoldenBiotech-Advancing First-line treatment of Meta. PanCa GOLDEN BIOTECHNOLOGY CORP. / 2025-08-10
- GlobalBio: 國鼎生技-開發Antroquinonol 造福抗癌研究治療 GOLDEN BIOTECHNOLOGY CORP. / 2025-08-10
- 現場校正、抽檢應用 攜帶式測量儀 XIN TOP CORPORATION / 2025-08-07
- Honya Medical Strengthens Local Presence and Expands Toward Global Clinical Excellence HONYA MEDICAL CO., LTD. / 2025-07-30
- Honya’s MiSaver: A New Frontier in Treating Heart Damage After Heart Attacks HONYA MEDICAL CO., LTD. / 2025-07-30
- AAVnerGene and TFBS Bioscience Announce Collaboration to Develop Innovative AAV Technology Platform TFBS BIOSCIENCE, INC. / 2025-07-25
- Visit Us at BIO Asia–Taiwan 2025! July 24 – July 27 GENERAL BIOLOGICALS CORPORATION (GBC) / 2025-07-25
- GBC CellBio™ a2000 has been recognized with a 2025 Edison Award. GENERAL BIOLOGICALS CORPORATION (GBC) / 2025-07-24
- GBC AI Biotech Building Officially Commissioned. GENERAL BIOLOGICALS CORPORATION (GBC) / 2025-07-24
- Your Invitation to Innovation – Booth M412 Forum MAJOR SCIENCE CO.,LTD / 2025-07-24
- Ecotek Engineering Corp.: Your Integrated Partner for Biopharma Facility and Process Equipment Solut MAJOR SCIENCE CO.,LTD / 2025-07-24
- About major science - Create life sciences research instruments through quality and innovation MAJOR SCIENCE CO.,LTD / 2025-07-24
- MarkerX Unveils MyeloTrak™ at BIO Asia, Redefining Multiple Myeloma Management with Non-invasive, Pr MARKER X CO., LTD. / 2025-07-23
- CancerFree Biotech Selected for OIST Startup Accelerator Program CANCERFREE BIOTECH LTD. / 2025-07-23
- AI Sparks a New Wave in Cancer Research: How a Taiwanese Startup Is Breaking Lab Bottlenecks and Ad CANCERFREE BIOTECH LTD. / 2025-07-23
- Transin Biomedical showcases the innovative strength of smart medical devices TRANSIN BIOMEDICAL CO., LTD. / 2025-07-23
- TaiMed Biologics Hosts Interactive Activities at BIO Asia 2025 to Promote HIV Awareness TAIMED BIOLOGICS INC. / 2025-07-22
- A Pioneer for Over Two Decades, Cell-Bio Biotechnology to Showcase Comprehensive Solutions at BioAsi CELL-BIO BIOTECHNOLOGY CO., LTD. / 2025-07-22